Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,989

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

The burden of disease in older people and implications for health policy and practice

Prince, Martin J, Wu, Fan, Guo, Yanfei, Gutierrez Robledo, Luis M, O'Donnell, Martin, Sullivan, Richard, Yusuf, Salim·2015·The Lancet

Abstract

23% of the total global burden of disease is attributable to disorders in people aged 60 years and older. Although the proportion of the burden arising from older people (≥60 years) is highest in high-income regions, disability-adjusted life years (DALYs) per head are 40% higher in low-income and middle-income regions, accounted for by the increased burden per head of population arising from cardiovascular diseases, and sensory, respiratory, and infectious disorders. The leading contributors to disease burden in older people are cardiovascular diseases (30·3% of the total burden in people aged 60 years and older), malignant neoplasms (15·1%), chronic respiratory diseases (9·5%), musculoskeletal diseases (7·5%), and neurological and mental disorders (6·6%). A substantial and increased proportion of morbidity and mortality due to chronic disease occurs in older people. Primary prevention in adults aged younger than 60 years will improve health in successive cohorts of older people, but much of the potential to reduce disease burden will come from more effective primary, secondary, and tertiary prevention targeting older people. Obstacles include misplaced global health priorities, ageism, the poor preparedness of health systems to deliver age-appropriate care for chronic diseases, and the complexity of integrating care for complex multimorbidities. Although population ageing is driving the worldwide epidemic of chronic diseases, substantial untapped potential exists to modify t…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(14)61347-7

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 104

  1. Kowal, 2010, Ageing and adult health status in eight lower-income countries: the INDEPTH WHO-SAGE collaboration, Glob Health Action, 3
  2. Cong, 2008, Smoking and the risk of age-related macular degeneration: a meta-analysis, Ann Epidemiol, 18, 647, 10.1016/j.annepidem.2008.04.002 · DOI
  3. Peto, 2000, Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies, BMJ, 321, 323, 10.1136/bmj.321.7257.323 · DOI
  4. Barnes, 2011, The projected effect of risk factor reduction on Alzheimer's disease prevalence, Lancet Neurol, 10, 819, 10.1016/S1474-4422(11)70072-2 · DOI
  5. Ostchega, 2007, Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004, J Am Geriatr Soc, 55, 1056, 10.1111/j.1532-5415.2007.01215.x · DOI
  6. Prince, 2012, Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: a 10/66 cross-sectional population-based survey, J Hypertens, 30, 177, 10.1097/HJH.0b013e32834d9eda · DOI
  7. 2001, Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: a multicentre study, Bull World Health Organ, 79, 490
  8. Reed, 1998, Predictors of healthy aging in men with high life expectancies, Am J Public Health, 88, 1463, 10.2105/AJPH.88.10.1463 · DOI
  9. Lewington, 2007, Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths, Lancet, 370, 1829, 10.1016/S0140-6736(07)61778-4 · DOI · Paper page
  10. Haveman-Nies, 2002, Dietary quality and lifestyle factors in relation to 10-year mortality in older Europeans: the SENECA study, Am J Epidemiol, 156, 962, 10.1093/aje/kwf144 · DOI
  11. Hrobonova, 2011, Higher levels and intensity of physical activity are associated with reduced mortality among community dwelling older people, J Aging Res, 2011, 651931, 10.4061/2011/651931 · DOI
  12. Gupta, 2005, Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study, Int J Epidemiol, 34, 1395, 10.1093/ije/dyi196 · DOI
  13. Jotheeswaran, 2010, Predictors of mortality among elderly people living in a south Indian urban community; a 10/66 Dementia Research Group prospective population-based cohort study, BMC Public Health, 10, 366, 10.1186/1471-2458-10-366 · DOI
  14. Pitner, 2005, Obesity in the elderly, Consult Pharm, 20, 498, 10.4140/TCP.n.2005.498 · DOI
  15. Grabowski, 2001, High body mass index does not predict mortality in older people: analysis of the Longitudinal Study of Aging, J Am Geriatr Soc, 49, 968, 10.1046/j.1532-5415.2001.49189.x · DOI
  16. Musini, 2009, Pharmacotherapy for hypertension in the elderly, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD000028.pub2 · DOI
  17. Sanderson, 1996, Hypertension in the elderly: pressure to treat?, Health Trends, 28, 71
  18. Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1 · DOI · Paper page
  19. Ostchega, 2008, Are demographic characteristics, health care access and utilization, and comorbid conditions associated with hypertension among US adults?, Am J Hypertens, 21, 159, 10.1038/ajh.2007.32 · DOI
  20. Gu, 2002, The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in china, Hypertension, 40, 920, 10.1161/01.HYP.0000040263.94619.D5 · DOI
  21. Gaziano, 2010, Growing epidemic of coronary heart disease in low- and middle-income countries, Curr Probl Cardiol, 35, 72, 10.1016/j.cpcardiol.2009.10.002 · DOI
  22. Deo, 2012, Invited commentary-Global arrhythmia burden: the public health implications of the rise in atrial fibrillation comment on “The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction”, Arch Intern Med, 172, 741, 10.1001/archinternmed.2012.1294 · DOI
  23. Lacey, 2005, Economic burden of post-acute myocardial infarction heart failure in the United Kingdom, Eur J Heart Fail, 7, 677, 10.1016/j.ejheart.2004.10.020 · DOI
  24. Schargrodsky, 2008, CARMELA: assessment of cardiovascular risk in seven Latin American cities, Am J Med, 121, 58, 10.1016/j.amjmed.2007.08.038 · DOI
  25. Ng, 2006, Combining risk factors and demographic surveillance: potentials of WHO STEPS and INDEPTH methodologies for assessing epidemiological transition, Scand J Public Health, 34, 199, 10.1080/14034940500204506 · DOI
  26. Deepa, 2003, The Chennai Urban Rural Epidemiology Study (CURES)–study design and methodology (urban component) (CURES-I), J Assoc Physicians India, 51, 863
  27. Ford, 2003, Changes in prevalence of nonfatal coronary heart disease in the United States from 1971–1994, Ethn Dis, 13, 85
  28. Xavier, 2008, Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data, Lancet, 371, 1435, 10.1016/S0140-6736(08)60623-6 · DOI
  29. Critchley, 2004, Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999, Circulation, 110, 1236, 10.1161/01.CIR.0000140668.91896.AE · DOI
  30. Gupta, 2008, Epidemiology and causation of coronary heart disease and stroke in India, Heart, 94, 16, 10.1136/hrt.2007.132951 · DOI
  31. Ortegón, 2012, Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study, BMJ, 344, e607, 10.1136/bmj.e607 · DOI
  32. Evans, 2005, Methods to assess the costs and health effects of interventions for improving health in developing countries, BMJ, 331, 1137, 10.1136/bmj.331.7525.1137 · DOI
  33. Gheorghiade, 2009, Digoxin for the treatment of chronic and acute heart failure syndromes, Acute Card Care, 11, 83, 10.1080/17482940902883246 · DOI
  34. Strong, 2007, Preventing stroke: saving lives around the world, Lancet Neurol, 6, 182, 10.1016/S1474-4422(07)70031-5 · DOI
  35. Adamson, 2004, Is stroke the most common cause of disability?, J Stroke Cerebrovasc Dis, 13, 171, 10.1016/j.jstrokecerebrovasdis.2004.06.003 · DOI
  36. Ferri, 2011, Prevalence of stroke and related burden among older people living in Latin America, India and China, J Neurol Neurosurg Psychiatry, 82, 1074, 10.1136/jnnp.2010.234153 · DOI
  37. Sousa, 2009, Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey, Lancet, 374, 1821, 10.1016/S0140-6736(09)61829-8 · DOI
  38. Sousa, 2010, The contribution of chronic diseases to the prevalence of dependence among older people in Latin America, China and India: a 10/66 Dementia Research Group population-based survey, BMC Geriatr, 10, 53, 10.1186/1471-2318-10-53 · DOI
  39. He, 2012, Prevalence of cardiovascular disease and risk factors in a rural district of Beijing, China: a population-based survey of 58,308 residents, BMC Public Health, 12, 34, 10.1186/1471-2458-12-34 · DOI
  40. Das, 2008, Prevalence of major neurological disorders among geriatric population in the metropolitan city of Kolkata, J Assoc Physicians India, 56, 175
  41. Sposato, 2012, Gross domestic product and health expenditure associated with incidence, 30-day fatality, and age at stroke onset: a systematic review, Stroke, 43, 170, 10.1161/STROKEAHA.111.632158 · DOI
  42. Yusuf, 2011, Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey, Lancet, 378, 1231, 10.1016/S0140-6736(11)61215-4 · DOI · Paper page
  43. Ma, 2008, Cancer care in China: A general review, Biomed Imaging Interv J, 4, e39, 10.2349/biij.4.3.e39 · DOI
  44. Brown, 2002, Estimating health care costs related to cancer treatment from SEER-Medicare data, Med Care, 40, IV-104
  45. Ginsberg, 2012, Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study, BMJ, 344, e614, 10.1136/bmj.e614 · DOI
  46. Aguilar-Salinas, 2003, Characteristics of patients with type 2 diabetes in México: Results from a large population-based nationwide survey, Diabetes Care, 26, 2021, 10.2337/diacare.26.7.2021 · DOI
  47. Buist, 2007, International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study, Lancet, 370, 741, 10.1016/S0140-6736(07)61377-4 · DOI
  48. Feenstra, 2001, The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands, Am J Respir Crit Care Med, 164, 590, 10.1164/ajrccm.164.4.2003167 · DOI
  49. Buist, 2008, Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative, Int J Tuberc Lung Dis, 12, 703
  50. Akgün, 2012, Epidemiology and management of common pulmonary diseases in older persons, J Gerontol A Biol Sci Med Sci, 67, 276, 10.1093/gerona/glr251 · DOI
  51. Aït-Khaled, 2008, COPD management. Part II. Relevance for resource-poor settings, Int J Tuberc Lung Dis, 12, 595
  52. Aït-Khaled, 2001, Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management, Bull World Health Organ, 79, 971
  53. Stanciole, 2012, Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study, BMJ, 344, e608, 10.1136/bmj.e608 · DOI
  54. Pascolini, 2012, Global estimates of visual impairment: 2010, Br J Ophthalmol, 96, 614, 10.1136/bjophthalmol-2011-300539 · DOI
  55. Vashist, 2011, Prevalence of cataract in an older population in India: the India study of age-related eye disease, Ophthalmology, 118, 272, 10.1016/j.ophtha.2010.05.020 · DOI
  56. Fletcher, 2010, Free radicals, antioxidants and eye diseases: evidence from epidemiological studies on cataract and age-related macular degeneration, Ophthalmic Res, 44, 191, 10.1159/000316476 · DOI
  57. Resnikoff, 2008, Global magnitude of visual impairment caused by uncorrected refractive errors in 2004, Bull World Health Organ, 86, 63, 10.2471/BLT.07.041210 · DOI
  58. Baltussen, 2012, Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study, BMJ, 344, e615, 10.1136/bmj.e615 · DOI
  59. Rao, 2011, The global burden of cataract, Curr Opin Ophthalmol, 22, 4, 10.1097/ICU.0b013e3283414fc8 · DOI
  60. Lewallen, 2009, Cataract surgical coverage remains lower in women, Br J Ophthalmol, 93, 295, 10.1136/bjo.2008.140301 · DOI
  61. Frick, 2009, Screening for refractive error and fitting with spectacles in rural and urban India: cost-effectiveness, Ophthalmic Epidemiol, 16, 378, 10.3109/09286580903312277 · DOI
  62. de Vugt, 2005, A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia, Int Psychogeriatr, 17, 577, 10.1017/S1041610205002292 · DOI
  63. Prince, 2003, Dementia diagnosis in developing countries: a cross-cultural validation study, Lancet, 361, 909, 10.1016/S0140-6736(03)12772-9 · DOI · Paper page
  64. Llibre Rodriguez, 2008, Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey, Lancet, 372, 464, 10.1016/S0140-6736(08)61002-8 · DOI
  65. Prince, 2012, Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort study, Lancet, 380, 50, 10.1016/S0140-6736(12)60399-7 · DOI
  66. Chan, 2013, Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis, Lancet, 381, 2016, 10.1016/S0140-6736(13)60221-4 · DOI
  67. Wimo, 2013, The worldwide economic impact of dementia 2010, Alzheimers Dement, 9, 1, 10.1016/j.jalz.2012.11.006 · DOI
  68. Mittelman, 1996, A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial, JAMA, 276, 1725, 10.1001/jama.1996.03540210033030 · DOI
  69. Jitapunkul, 2009, Undiagnosed dementia and value of serial cognitive impairment screening in developing countries: a population-based study, Geriatr Gerontol Int, 9, 47, 10.1111/j.1447-0594.2008.00501.x · DOI
  70. Reveille, 2013, The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States, Am J Med Sci, 345, 431, 10.1097/MAJ.0b013e318294457f · DOI
  71. Hoy, 2012, A systematic review of the global prevalence of low back pain, Arthritis Rheum, 64, 2028, 10.1002/art.34347 · DOI
  72. Woolf, 2003, Burden of major musculoskeletal conditions, Bull World Health Organ, 81, 646
  73. Morlion, 2013, Chronic low back pain: pharmacological, interventional and surgical strategies, Nat Rev Neurol, 9, 462, 10.1038/nrneurol.2013.130 · DOI
  74. Bijlsma, 2011, Osteoarthritis: an update with relevance for clinical practice, Lancet, 377, 2115, 10.1016/S0140-6736(11)60243-2 · DOI
  75. Zhang, 2008, OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines, Osteoarthritis Cartilage, 16, 137, 10.1016/j.joca.2007.12.013 · DOI · Paper page
  76. 2009, Ageism and age discrimination in secondary health care in the United Kingdom. A review from the literature commissioned by the Department of Health
  77. Ramsay, 2005, Secondary prevention of coronary heart disease in older British men: extent of inequalities before and after implementation of the National Service Framework, J Public Health (Oxf), 27, 338, 10.1093/pubmed/fdi053 · DOI
  78. Luker, 2011, Patients' age as a determinant of care received following acute stroke: a systematic review, BMC Health Serv Res, 11, 161, 10.1186/1472-6963-11-161 · DOI
  79. Avezum, 2005, Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE), Am Heart J, 149, 67, 10.1016/j.ahj.2004.06.003 · DOI
  80. Preston, 2008, Geriatric surgery is about disease, not age, J R Soc Med, 101, 409, 10.1258/jrsm.2008.080035 · DOI
  81. Turner, 1999, Cancer in old age--is it inadequately investigated and treated?, BMJ, 319, 309, 10.1136/bmj.319.7205.309 · DOI
  82. Konrat, 2012, Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs, PLoS One, 7, e33559, 10.1371/journal.pone.0033559 · DOI
  83. Albanese, 2011, Equity in the delivery of community healthcare to older people: findings from 10/66 Dementia Research Group cross-sectional surveys in Latin America, China, India and Nigeria, BMC Health Serv Res, 11, 153, 10.1186/1472-6963-11-153 · DOI
  84. Roy, 2008, Influence of socioeconomic status, wealth and financial empowerment on gender differences in health and healthcare utilization in later life: evidence from India, Soc Sci Med, 66, 1951, 10.1016/j.socscimed.2008.01.015 · DOI
  85. Dachs, 2002, Inequalities in health in Latin America and the Caribbean: descriptive and exploratory results for self-reported health problems and health care in twelve countries, Rev Panam Salud Publica, 11, 335, 10.1590/S1020-49892002000500009 · DOI
  86. Wolff, 2002, Prevalence, expenditures, and complications of multiple chronic conditions in the elderly, Arch Intern Med, 162, 2269, 10.1001/archinte.162.20.2269 · DOI
  87. Caughey, 2010, Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study, J Epidemiol Community Health, 64, 1036, 10.1136/jech.2009.088260 · DOI
  88. Kirchberger, 2012, Patterns of multimorbidity in the aged population. Results from the KORA-Age study, PLoS One, 7, e30556, 10.1371/journal.pone.0030556 · DOI
  89. Khanam, 2011, Prevalence and patterns of multimorbidity among elderly people in rural Bangladesh: a cross-sectional study, J Health Popul Nutr, 29, 406, 10.3329/jhpn.v29i4.8458 · DOI
  90. Fortin, 2006, Relationship between multimorbidity and health-related quality of life of patients in primary care, Qual Life Res, 15, 83, 10.1007/s11136-005-8661-z · DOI
  91. Wolff, 2005, Newly reported chronic conditions and onset of functional dependency, J Am Geriatr Soc, 53, 851, 10.1111/j.1532-5415.2005.53262.x · DOI
  92. Lacas, 2012, Frailty in primary care: a review of its conceptualization and implications for practice, BMC Med, 10, 4, 10.1186/1741-7015-10-4 · DOI
  93. De Lepeleire, 2009, Frailty: an emerging concept for general practice, Br J Gen Pract, 59, e177, 10.3399/bjgp09X420653 · DOI
  94. Fried, 2004, Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care, J Gerontol A Biol Sci Med Sci, 59, 255, 10.1093/gerona/59.3.M255 · DOI · Paper page
  95. Ensrud, 2008, Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women, Arch Intern Med, 168, 382, 10.1001/archinternmed.2007.113 · DOI · Paper page
  96. Strawbridge, 1998, Antecedents of frailty over three decades in an older cohort, J Gerontol B Psychol Sci Soc Sci, 53, S9, 10.1093/geronb/53B.1.S9 · DOI
  97. Avila-Funes, 2009, Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study, J Am Geriatr Soc, 57, 453, 10.1111/j.1532-5415.2008.02136.x · DOI
  98. van Weel, 2006, Comorbidity and guidelines: conflicting interests, Lancet, 367, 550, 10.1016/S0140-6736(06)68198-1 · DOI
  99. Fortin, 2007, Multimorbidity's many challenges, BMJ, 334, 1016, 10.1136/bmj.39201.463819.2C · DOI
  100. Daniels, 2008, Interventions to prevent disability in frail community-dwelling elderly: a systematic review, BMC Health Serv Res, 8, 278, 10.1186/1472-6963-8-278 · DOI
  101. Lloyd-Sherlock, 2012, Population ageing and health, Lancet, 379, 1295, 10.1016/S0140-6736(12)60519-4 · DOI
  102. House, 2005, Continuity and change in the social stratification of aging and health over the life course: evidence from a nationally representative longitudinal study from 1986 to 2001/2002 (Americans' Changing Lives Study), J Gerontol B Psychol Sci Soc Sci, 60, 15, 10.1093/geronb/60.Special_Issue_2.S15 · DOI · Paper page
  103. Luengo-Fernandez R, Leal J, Gray A. Dementia 2010. The prevalence, economic cost and research funding of dementia compared with other major diseases. A report produced by the Health Economics Research Centre, University of Oxford for the Alzheimer's Research Trust. 2010. Cambridge, Alzheimer's Research Trust.
  104. Salomon, 2012, Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010, Lancet, 380, 2129, 10.1016/S0140-6736(12)61680-8 · DOI · Paper page

Cited by

See all 1,989

Metadata

Authors
Prince, M. J., Wu, F., Guo, Y., Gutierrez Robledo, L. M., O'Donnell, M., Sullivan, R., & Yusuf, S.
Venue
The Lancet
Publisher
Elsevier BV
Published
2015-02
Volume
385
Issue
9967
Pages
549-562
ISSN
0140-6736
Cited by
1,989
References
20
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.